AI assistant
Sending…
Enveric Biosciences, Inc. — Director's Dealing 2021
Sep 27, 2021
35460_dirs_2021-09-27_f578868a-c1d5-4196-a740-650ad2af4c88.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Enveric Biosciences, Inc. (ENVB)
CIK: 0000890821
Period of Report: 2021-09-16
Reporting Person: Thompson Bradley George (Director)
More from Enveric Biosciences, Inc.
Regulatory Filings
2026
May 29
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 15
Regulatory Filings
2026
May 4
Regulatory Filings
2026
Apr 30
Proxy Solicitation & Information Statement
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 29
Regulatory Filings
2026
Apr 23
Regulatory Filings
2026
Apr 18